Welcome to our dedicated page for International Flavors&Fragranc news (Ticker: IFF), a resource for investors and traders seeking the latest updates and insights on International Flavors&Fragranc stock.
International Flavors & Fragrances Inc. (NYSE: IFF) is a global leader in sensory experiences and specialty ingredients, serving industries from food technology to pharmaceutical solutions. This dedicated news hub provides investors and industry professionals with essential updates on IFF developments, including earnings reports, strategic partnerships, and scientific breakthroughs.
Key resources include: Quarterly financial results, innovation announcements in flavors/fragrances, bioscience advancements, and sustainability initiatives. Our curated collection ensures access to verified press releases and market analyses that impact IFF's position in the $120B+ specialty chemicals sector.
Bookmark this page for real-time updates on IFF's product launches, regulatory milestones, and leadership changes. Combine technical insights with strategic context to make informed decisions about this NYSE-listed innovator.
IFF has achieved a breakthrough in encapsulation technology, successfully encapsulating liquid curcumin using its patented SeaGel® in vegan softgel formats. This marks the industry’s first successful application of high viscosity liquid ingredients in plant-based supplements. This innovation allows manufacturers to produce high-quality soft-shell capsules that meet the growing consumer demand for plant-based dietary options.
The collaboration with AQUANOVA AG highlights IFF's commitment to address the challenges faced in developing softgel technology for dietary supplements, expanding the efficacy and application scope of natural ingredients.
International Flavors & Fragrances (IFF) announced that TRC Capital Investment Corporation has made an unsolicited mini-tender offer to purchase up to 1,500,000 shares at $81.60 per share, a 1.4% discount from the March 17 closing price of $82.76. IFF advises shareholders not to tender their shares, as the offer price is below market value and contingent upon several conditions. The offer expires on April 4, 2023, unless extended. IFF does not endorse this bid and highlights that such offers lack the protections outlined by SEC rules. Shareholders are encouraged to consult market prices and seek advice from financial advisors.
Danisco Animal Nutrition & Health, a unit of IFF, launched Axtra® PRIME, an optimized enzyme blend for piglet production, on March 14, 2023, in the U.S.. This product aims to enhance nutrient digestion, improving gut health and piglet performance during critical early growth stages. The blend includes xylanase, beta-glucanase, alpha-amylase, and protease enzymes, tailored to address challenges like weaning stress and dietary variability that can impact feed efficiency. Research demonstrates significant benefits of this enzyme formulation on piglet growth and producer profitability.
IFF (NYSE: IFF) has declared a quarterly cash dividend of $0.81 per share, payable on April 6, 2023, to shareholders of record as of March 24, 2023. This decision reflects the company's commitment to returning value to its shareholders while maintaining financial stability. IFF continues to lead in the food, beverage, scent, health, and biosciences sectors, merging science and creativity to deliver essential solutions. Stay informed about IFF's initiatives and updates by visiting iff.com.
International Flavors & Fragrances (NYSE: IFF) is evolving its Board of Directors to enhance its strategic transformation and financial vision. Effective March 10, 2023, Kevin O’Byrne, CFO of J Sainsbury Plc, will join the Board, bringing extensive experience in consumer retail. He will serve on the Audit, Innovation, and Transaction Committees. Meanwhile, Ed Breen, Matthias Heinzel, and Stephen Williamson will retire from the Board, with Williamson's departure also effective March 10. The Chairman expressed gratitude for their contributions, emphasizing the company’s commitment to long-term growth and innovation under new leadership.
IFF (NYSE: IFF) has agreed to sell its Flavor Specialty Ingredients (FSI) business to UK-based private equity firm Exponent for $220 million. The sale aims to strengthen IFF's financial profile by reducing outstanding debt and allowing the company to concentrate on core operations. FSI is a leading manufacturer of aroma chemicals for the flavor market, generating over $100 million in revenue in the past year. The transaction is expected to close by the end of Q3 2023, pending customary conditions.
IFF (NYSE: IFF) will present at the Consumer Analyst Group of New York (CAGNY) conference in Boca Raton, Florida, on Thursday, Feb. 23, at 1:00 PM ET. The event will be accessible via live webcast and slide presentation on the company's website.
Investors can also access a recorded version of the presentation afterward. IFF is a leader in food, beverage, scent, health, and biosciences, focusing on innovative solutions that enhance quality of life globally. More information about IFF can be found on their website at ir.iff.com.
International Flavors & Fragrances reported Q4 2022 net sales of $2.84 billion, a 6% decline year-over-year, but currency neutral sales rose 4%. The company experienced a loss before taxes of $5 million, with adjusted operating EBITDA at $441 million, reflecting a 15.5% margin. For the full year, sales reached $12.44 billion, marking a 7% increase, although a reported loss of $1.63 billion was noted. Management aims for around $12.5 billion in sales for 2023, with flat adjusted operating EBITDA growth. The anticipated divestiture of Savory Solutions is expected to impact these figures.
International Flavors & Fragrances (IFF) announced the promotion of three perfumers, Juliette Karagueuzoglou, Nicolas Beaulieu, and Jean-Christophe Hérault, to vice president perfumers. This title is awarded for exceptional creativity and significant contributions to the fragrance industry. The newly promoted individuals have a track record of creating iconic fragrances and participating in strategic innovation projects, focusing on natural ingredients and new technologies. Their leadership will continue to shape the future of perfumery at IFF, emphasizing mentorship and the application of both science and creativity for industry advancement.
IFF (NYSE: IFF) has announced significant changes to its Board of Directors, aiming to align with best-in-class corporate governance standards. Effective from the 2023 Annual Shareholder Meeting, Roger W. Ferguson, Jr. will succeed Dale F. Morrison as Chair following Morrison's retirement for health reasons. Newly appointed directors include Mark J. Costa, Dawn Willoughby, and Gary Hu, while Michael Ducker, Ilene Gordon, and Kare Schultz will retire. The Board will be reduced to ten members by the upcoming meeting, reflecting a strategic transformation as IFF continues to enhance leadership and governance.